The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...
They will be offering the human papillomavirus (HPV) vaccine that helps protect against types of the virus that can cause cancers of the cervix, anus, mouth, penis and more.